ENTEROME has a total of 38 patent applications. It increased the IP activity by 16.0%. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are NANJING PRACTICE MEDICINE EXAMINATION CO LTD, CTRC RES FOUNDATION and COURTAGEN LIFE SCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | United States | 6 | |
#3 | Australia | 4 | |
#4 | Canada | 4 | |
#5 | China | 4 | |
#6 | EPO (European Patent Office) | 4 | |
#7 | Brazil | 2 | |
#8 | Mexico | 2 | |
#9 | France | 1 | |
#10 | Israel | 1 | |
#11 | India | 1 | |
#12 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry | |
#4 | Environmental technology | |
#5 | Computer technology | |
#6 | Measurement | |
#7 | Medical technology |
# | Name | Total Patents |
---|---|---|
#1 | Pichaud Matthieu | 14 |
#2 | Ehrlich Stanislav | 10 |
#3 | Cervino Alessandra | 10 |
#4 | Rimbaud Pierre | 10 |
#5 | Bonny Christophe | 5 |
#6 | Chene Laurent | 5 |
#7 | Plassais Jonathan | 5 |
#8 | Sivignon Adeline | 4 |
#9 | Bouckaert Julie | 4 |
#10 | Mathieu Alban | 4 |
Publication | Filing date | Title |
---|---|---|
WO2020021113A1 | Process for preparing mannose derivatives | |
EP3697924A1 | New tools for assessing fimh blockers therapeutic efficiency | |
WO2018065628A2 | Microbiota sequence variants of tumor-related antigenic epitopes | |
US2018235991A1 | Mannose derivatives useful for treating pathologies associated with adherent E. coli | |
EP3250710A1 | Host dna as a biomarker of crohn's disease |